Our EC-funded project, (FP6 contract No. 031867), "Development of an Implanted Biosensor for Continuous Care and Monitoring System of Diabetic Patients", addresses the pressing needs for the improvement of Blood Glucose monitoring and management through the development of an implanted sensor. This reagentless device integrates a novel nanobiotechnological glucose-sensing array at the heart of a ground-breaking fluorimetric detector, itself using an innovative hydrogel waveguide technology. The implant will wirelessly feed a sustained stream of Glucose values into a networked telemedicine system that will be able to support thousands of diabetic patients, and is planned to eventually integrate an insulin pump, thus fulfilling the ultimate goal of devising a cybernetic, externally supervised "artificial pancreas".
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/IEMBS.2007.4353731 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!